|
29 Companies |
|
28 Products |
|
28 Products |
|
27 Mechanisms of Action |
|
0 Trials |
|
447 News |
|
| «12345678910» |
- Trial completion: Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study (clinicaltrials.gov) - Aug 21, 2013
P=N/A, N=34, Completed, Sponsor: Seoul National University Hospital
Not yet recruiting --> Completed
- | clindamycin phosphate / Generic mfg.
Trial completion: W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers (clinicaltrials.gov) - Aug 21, 2013
P1, N=37, Completed, Sponsor: Stiefel, a GSK Company
Not yet recruiting --> Completed Not yet recruiting --> Completed
- ||| minocycline / Generic mfg.
Enrollment change: Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients (clinicaltrials.gov) - Aug 13, 2013
P2, N=150, Completed, Sponsor: Foamix Ltd.
Not yet recruiting --> Completed N=120 --> 150
- |||| minocycline / Generic mfg.
Trial completion: Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients (clinicaltrials.gov) - Aug 13, 2013
P2, N=150, Completed, Sponsor: Foamix Ltd.
N=120 --> 150 Recruiting --> Completed
- ||| Metvixia (methyl aminolevulinate hydrochloride 16.8% cream) / Galderma
Enrollment change: Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne (clinicaltrials.gov) - Aug 6, 2013
P2, N=150, Completed, Sponsor: PhotoCure
Recruiting --> Completed N=190 --> 150
- |||||||||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
New P3 trial: A Efficacy and Safety of Duac (clinicaltrials.gov) - Aug 1, 2013
P3, N=1020, Active, not recruiting, Sponsor: GlaxoSmithKline
- ||| clindamycin/tretinoin / Generic mfg.
New P1 trial: W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers (clinicaltrials.gov) - Aug 1, 2013
P1, N=64, Completed, Sponsor: GlaxoSmithKline
- ||| Enrollment closed: BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Aug 1, 2013
P2, N=300, Active, not recruiting, Sponsor: Braintree Laboratories
N=190 --> 150 Recruiting --> Active, not recruiting
- |||||||||| adapalene/benzoyl peroxide / Generic mfg.
New P3 trial: A Long Term Study of GK530G in Subjects With Acne Vulgaris (clinicaltrials.gov) - Jul 25, 2013
P3, N=436, Active, not recruiting, Sponsor: Galderma R&D
- Enrollment closed, HEOR: Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life (clinicaltrials.gov) - Jul 17, 2013
P=N/A, N=60, Active, not recruiting, Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- adapalene/benzoyl peroxide / Generic mfg.
Trial completion: SKADI: Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin (clinicaltrials.gov) - Jul 4, 2013
P4, N=60, Completed, Sponsor: University of Magdeburg
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment open: Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne (clinicaltrials.gov) - Jun 27, 2013
P2, N=18, Recruiting, Sponsor: The University of Western Australia
Recruiting --> Completed Not yet recruiting --> Recruiting
- dapsone / Generic mfg.
New P4 trial: Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel (clinicaltrials.gov) - Jun 23, 2013
P4, N=30, Recruiting, Sponsor: Derm Research, PLLC
- |||||||||| adapalene/benzoyl peroxide / Generic mfg.
New P3 trial: Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris (clinicaltrials.gov) - Jun 16, 2013
P3, N=493, Active, not recruiting, Sponsor: Galderma R&D
- ||| dapsone / Generic mfg.
Trial completion: Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris (clinicaltrials.gov) - Jun 16, 2013
P1, N=77, Completed, Sponsor: Allergan
Not yet recruiting --> Recruiting Recruiting --> Completed
- | Stelara (ustekinumab) / J&J
Enrollment closed: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa (clinicaltrials.gov) - Jun 12, 2013
P2, N=20, Active, not recruiting, Sponsor: University Medical Centre Groningen
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial suspension: Efficacy of Handheld Acne Heat Device (clinicaltrials.gov) - Jun 2, 2013
P4, N=20, Suspended, Sponsor: University of British Columbia
Recruiting --> Active, not recruiting Not yet recruiting --> Suspended
- | isotretinoin / Generic mfg.
New P1 trial: Bioequivalence Study for an Isotretinoin (clinicaltrials.gov) - May 27, 2013
P1, N=36, Completed, Sponsor: GlaxoSmithKline
- ||||||| Trial completion: A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne (clinicaltrials.gov) - May 14, 2013
P3, N=98, Completed, Sponsor: KLOX Technologies Inc.
Not yet recruiting --> Suspended Recruiting --> Completed
- ||||| berdazimer sodium (SB204) / Sato Pharma, Novan
New P2 trial: A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne (clinicaltrials.gov) - Apr 29, 2013
P2, N=153, Completed, Sponsor: Novan, Inc.
- | berdazimer sodium (SB204) / Sato Pharma, Novan
New P1 trial: A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel (clinicaltrials.gov) - Apr 29, 2013
P1, N=30, Completed, Sponsor: Novan, Inc.
- ||||| New P2 trial: BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Mar 19, 2013
P2, N=300, Active, not recruiting, Sponsor: Braintree Laboratories
- dapsone / Generic mfg.
Trial withdrawal, Adherence: An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris (clinicaltrials.gov) - Feb 21, 2013
P1, N=0, Withdrawn, Sponsor: Allergan
Recruiting --> Completed Not yet recruiting --> Withdrawn
- dapsone / Generic mfg.
Enrollment change, Adherence: An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris (clinicaltrials.gov) - Feb 21, 2013
P1, N=0, Withdrawn, Sponsor: Allergan
Not yet recruiting --> Withdrawn N=72 --> 0
- |||| Trial completion: A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac (clinicaltrials.gov) - Feb 21, 2013
P2, N=153, Completed, Sponsor: PhotoCure
N=72 --> 0 Active, not recruiting --> Completed
- Trial completion: Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne (clinicaltrials.gov) - Feb 18, 2013
P=N/A, N=100, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
New P3 trial: Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris (clinicaltrials.gov) - Feb 7, 2013
P3, N=708, Completed, Sponsor: Watson Laboratories, Inc.
- dapsone / Generic mfg.
New P1 trial, Adherence: An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris (clinicaltrials.gov) - Feb 5, 2013
P1, N=0, Withdrawn, Sponsor: Allergan
- | drospirenone/ethinyl estradiol / Generic mfg.
Trial initiation date: Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne (clinicaltrials.gov) - Jan 28, 2013
P3, N=30, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Initiation date: Jul 2008 --> Apr 2009
- || drospirenone/ethinyl estradiol / Generic mfg.
Trial completion: Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne (clinicaltrials.gov) - Jan 28, 2013
P3, N=30, Completed, Sponsor: Massachusetts General Hospital
Initiation date: Jul 2008 --> Apr 2009 Active, not recruiting --> Completed
- ||| dapsone / Generic mfg.
New P1 trial: Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris (clinicaltrials.gov) - Jan 21, 2013
P1, N=77, Completed, Sponsor: Allergan
- |||| Seysara (sarecycline) / Paratek, Almirall
Trial completion: Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris (clinicaltrials.gov) - Jan 17, 2013
P2, N=285, Completed, Sponsor: Warner Chilcott
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
New P1 trial: A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac (clinicaltrials.gov) - Jan 15, 2013
P1, N=650, Completed, Sponsor: Taro Pharmaceuticals USA
- |||| Trial completion: Clinical Trial To Evaluate ANT-1207 In Subjects With Acne (clinicaltrials.gov) - Jan 15, 2013
P2, N=72, Completed, Sponsor: Anterios Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- ||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
New P1 trial: Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya (clinicaltrials.gov) - Jan 14, 2013
P1, N=1215, Completed, Sponsor: Taro Pharmaceuticals USA
- Trial initiation date: Efficacy of Handheld Acne Heat Device (clinicaltrials.gov) - Jan 8, 2013
P4, N=20, Suspended, Sponsor: University of British Columbia
Recruiting --> Completed Initiation date: Jul 2012 --> Jul 2013
- Enrollment change: Effects of Acleara Needle Insert on Acne (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=30, Completed, Sponsor: Theravant Corporation
Initiation date: Jul 2012 --> Jul 2013 N=15 --> 30
- | Trial completion: Effects of Acleara Needle Insert on Acne (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=30, Completed, Sponsor: Theravant Corporation
N=15 --> 30 Recruiting --> Completed
- || New P3 trial: Effects of Omega-3 Fatty Acid Supplementation in Acne Patients (clinicaltrials.gov) - Jan 7, 2013
P3, N=90, Active, not recruiting, Sponsor: University of California, Los Angeles
- Trial withdrawal: Photodynamic Therapy in the Treatment of Acne (clinicaltrials.gov) - Dec 26, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Michigan
Recruiting --> Completed Terminated --> Withdrawn
- Enrollment change: Photodynamic Therapy in the Treatment of Acne (clinicaltrials.gov) - Dec 26, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Michigan
Terminated --> Withdrawn N=75 --> 0
- | minocycline / Generic mfg.
New P1 trial: Bioequivalence Minocycline Bioequivalence (clinicaltrials.gov) - Dec 20, 2012
P1, N=25, Completed, Sponsor: GlaxoSmithKline
- | adapalene/benzoyl peroxide / Generic mfg.
Trial completion, Adherence: Effect of Samples on Acne Treatment With Epiduo (clinicaltrials.gov) - Dec 6, 2012
P=N/A, N=20, Completed, Sponsor: Wake Forest University
N=75 --> 0 Recruiting --> Completed
- ||| adapalene/benzoyl peroxide / Generic mfg.
New P1 trial: Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo (clinicaltrials.gov) - Dec 3, 2012
P1, N=2008, Completed, Sponsor: Taro Pharmaceuticals USA
- dapsone / Generic mfg., adapalene / Generic mfg.
Trial withdrawal: Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne (clinicaltrials.gov) - Nov 15, 2012
P1, N=0, Withdrawn, Sponsor: Allergan
Recruiting --> Completed Not yet recruiting --> Withdrawn
- dapsone / Generic mfg., adapalene / Generic mfg.
Enrollment change: Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne (clinicaltrials.gov) - Nov 15, 2012
P1, N=0, Withdrawn, Sponsor: Allergan
Not yet recruiting --> Withdrawn N=64 --> 0
- Trial completion: Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris (clinicaltrials.gov) - Oct 20, 2012
P1, N=31, Completed, Sponsor: Miglani, Anjali
N=64 --> 0 Active, not recruiting --> Completed
- Trial completion: Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris (clinicaltrials.gov) - Oct 20, 2012
P1, N=32, Completed, Sponsor: Miglani, Anjali
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | New P4 trial: U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne (clinicaltrials.gov) - Oct 11, 2012
P4, N=28, Completed, Sponsor: Stiefel, a GSK Company
- | New P4 trial: U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY (clinicaltrials.gov) - Oct 11, 2012
P4, N=20, Completed, Sponsor: Stiefel, a GSK Company